AMBALAL SARABHAI ENT L Share Price

AMBALAL SARABHAI ENT L Share Price

NSE: AMBALALSA
|
Pharmaceuticals
|
S Cap
₹ 40.58
+₹1.93 (4.99%)
1D
Last updated 23 Sep, 2026, 15:23 IST

AMBALAL SARABHAI ENT L Share Price Today

As of 24 Sep 2026, AMBALAL SARABHAI ENT L share price is ₹40.58. The stock opened at ₹39.24, compared to its previous close of ₹38.65. During today's trading session, AMBALAL SARABHAI ENT L share price moved in the range of ₹38.80 to ₹40.58, with an average price of ₹39.69 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.15 and a high of ₹49.98. On the performance front, AMBALAL SARABHAI ENT L share price has increased by 14.81% over the last six months and is up 14.81% on a year-on-year basis.

₹38.80
4.99% up today
₹40.58
1D LOW
1D HIGH

AMBALAL SARABHAI ENT L Returns Calculator

Circuit
L
H
₹36.72
₹40.58
52-week
L
H
₹30.15
₹49.98

About AMBALAL SARABHAI ENT L

AMBALAL SARABHAI ENT L Share Price
ISIN
INE432A01017
Sector Market Cap
₹ 308.30 Cr

Ambalal Sarabhai Enterprises Limited is an India-based company that is engaged in the business of manufacturing pharmaceuticals and electronics. The Company's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparations (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in the oncology, infertility and Uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Pvt. Ltd., is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited, is a manufacturer of analytical and test and measuring instruments, distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.

AMBALAL SARABHAI ENT L Financial Highlights

  • Revenue: AMBALAL SARABHAI ENT L reported revenue of ₹217.44 crore in FY26 vs ₹207.57 crore in FY25. It showed an increase of 4.76% on a yearly basis.
  • Operating Profit: AMBALAL SARABHAI ENT L reported an operating profit of ₹18.51 crore in FY26 vs ₹4.83 crore in FY25. It showed an increase of 283.23% on a year-on-year basis.
  • Net Profit: AMBALAL SARABHAI ENT L reported a net profit of ₹17.80 crore in FY26 vs ₹4.93 crore in FY25. It showed an increase of 261.05% on a yearly basis.

AMBALAL SARABHAI ENT L Quarterly Result Highlights

  • AMBALAL SARABHAI ENT L reported revenue of ₹45.59 crore in Jun 2026, compared with ₹68.10 crore in Mar 2026, representing a decrease of 33.05% on a quarter-on-quarter (QoQ) basis.
  • AMBALAL SARABHAI ENT L reported an operating profit of ₹4.68 crore in Jun 2026, compared with ₹6.25 crore in Mar 2026, representing a decrease of 25.12% on a quarter-on-quarter (QoQ) basis.
  • AMBALAL SARABHAI ENT L reported a profit of ₹3.98 crore in Jun 2026, compared with ₹6.50 crore in Mar 2026, reflecting a decrease of 38.77% on a QoQ basis.
  • The earnings per share (EPS) of AMBALAL SARABHAI ENT L stood at ₹2.32 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
31.36%
FII
0.00%
Other DII
0.01%
Retail and other
68.64%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.34%
Dec 20250.34%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
297.49
P/E
22.73
P/B
1.95
ROE
11.24%
D/E
0.19
ROCE
10.51%
Div. Yield
0.00%
EPS(TTM)
1.43
Turnover
0.03
EV/EBITDA
14.05
Net Margin
278.93%
Op. Margin
265.23%
ROA
4.82%
Quick Ratio
1.80
Curr. Ratio
2.81
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Ambalal Sarabhai has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Ambalal Sarabhai appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Ambalal Sarabhai earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

AMBALAL SARABHAI ENT L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹202.27₹196.19₹173.57₹170.28
Other Income₹15.17₹11.38₹10.37₹12.49
Total Revenue₹217.44₹207.57₹183.95₹182.77
Total Expenses₹198.54₹196.38₹174.58₹166.91
Profit Before Tax₹18.51₹4.83₹6.65₹15.17
Tax₹0.70-₹0.10₹0.97₹3.72
Profit After Tax₹17.80₹4.93₹5.68₹11.45
EPS - Basic₹2.32₹0.64₹0.74₹1.49
EPS - Diluted₹2.32₹0.64₹0.74₹1.49

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹18.51₹4.83₹6.65₹15.17
Income before WC changes₹15.60₹7.03₹11.12₹14.57
Change in Assets₹2.87-₹38.35₹0.42-₹0.96
Change in Liabilities-₹5.55₹16.91₹1.35-₹3.48
Change in WC-₹2.68-₹21.43₹1.77-₹4.43
Cash flow from Operations₹13.40-₹17.62₹8.89₹5.72
Cash flow from Investing-₹10.25₹13.26-₹5.30-₹16.78
Cash flow from Financing-₹1.85-₹1.52-₹2.95₹9.09
Total Cash Flow₹1.30-₹5.88₹0.65-₹1.97
Cash (Start of the year)₹4.89₹10.78₹10.13₹12.10
Cash (End of the year)₹6.19₹4.89₹10.78₹10.13

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹156.10₹153.08₹130.98₹134.80
Current Assets₹125.03₹118.59₹118.54₹110.94
Total Assets₹281.13₹271.68₹249.52₹245.74
Current Liabilities₹98.54₹120.51₹102.32₹102.87
Net Current Asset₹26.49-₹1.92₹16.23₹8.07
Non-Current Liabilities₹24.22₹11.18₹10.78₹11.94
Equity Capital₹158.36₹139.98₹136.42₹130.93
Total Equity & Liabilities₹281.13₹271.68₹249.52₹245.74

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3.94₹4.04₹3.81₹3.71
Other Income₹15.57₹15.29₹7.89₹10.53
Total Revenue₹19.52₹19.33₹11.70₹14.24
Total Expenses₹9.57₹11.81₹10.89₹9.12
Profit Before Tax₹9.95₹8.08₹0.81₹4.34
Tax-₹1.04-₹0.16-₹1.77₹0.23
Profit After Tax₹10.99₹8.24₹2.58₹4.11
EPS - Basic₹1.43₹1.08₹0.34₹0.54
EPS - Diluted₹1.43₹1.08₹0.34₹0.54

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹9.95₹8.08₹0.81₹4.34
Income before WC changes₹0.20-₹6.15-₹3.16-₹1.37
Change in Assets-₹0.42₹2.33-₹1.91₹2.70
Change in Liabilities-₹2.88₹0.38₹1.93₹0.98
Change in WC-₹3.30₹2.71₹0.02₹3.68
Cash flow from Operations-₹0.26-₹4.08-₹3.82₹1.52
Cash flow from Investing-₹3.02₹6.35₹3.48₹0.61
Cash flow from Financing₹3.40-₹2.31₹0.30-₹3.76
Total Cash Flow₹0.11-₹0.04-₹0.04-₹1.63
Cash (Start of the year)₹0.08₹0.13₹0.17₹1.80
Cash (End of the year)₹0.20₹0.08₹0.13₹0.17

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹44.09₹44.30₹44.79₹45.35
Current Assets₹41.71₹38.62₹36.49₹34.40
Total Assets₹85.79₹82.92₹81.28₹79.74
Current Liabilities₹23.14₹34.12₹40.65₹41.49
Net Current Asset₹18.56₹4.50-₹4.16-₹7.09
Non-Current Liabilities₹3.17₹0.30₹0.34₹0.41
Equity Capital₹59.48₹48.49₹40.29₹37.85
Total Equity & Liabilities₹85.79₹82.92₹81.28₹79.74
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
47.86
Neutral
ATR (14)
1.98
Neutral
STOCH(9,6)
64.11
Neutral
STOCH RSI (14)
60.45
Neutral
ADX(9)
25.78
Bearish
UO(9)
50.4
Neutral
ROC(12)
-7.2
Bearish
WillR(14)
-59.41
Neutral
Period
Simple value
Exponential vaue
5D
39.84
39.84
10D
40.19
40.38
20D
41.92
41.18
50D
40.18
40.03
100D
36.35
41.27
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
AMBALAL SARABHAI ENT L Share Price
AMBALAL SARABHAI ENT L
Pharmaceuticals
Add Stock
Add Another

AMBALAL SARABHAI ENT L Share Price FAQs

AMBALAL SARABHAI ENT L share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837